Status Epilepticus — Adult

Key Points

• Treat convulsive seizure activity at 5 minutes as status epilepticus.
• Use a full weight-appropriate benzodiazepine dose rather than serial ineffective microdoses.
• IM midazolam is an evidence-based first-line option when IV access is delayed.
• If seizure continues, promptly load levetiracetam, fosphenytoin, or valproate at established status doses.
• Persistent altered consciousness after motor activity stops may represent nonconvulsive status and requires EEG.
• Always check glucose early and correct major metabolic triggers in parallel with antiseizure treatment.
• Refractory status requires ICU-level airway management, continuous EEG, and anesthetic therapy.
• Identify disease-specific causes such as eclampsia, meningitis, toxic ingestion, stroke, or alcohol withdrawal because definitive treatment differs.

Algorithm

1. At 5 minutes of ongoing convulsion, begin status treatment while supporting airway, oxygenation, circulation, and checking glucose.
2. Give IV lorazepam or IM midazolam at an adequate weight-based adult dose.
3. Repeat the benzodiazepine once if needed while preparing a second-line antiseizure load.
4. Load levetiracetam, fosphenytoin, or valproate if seizure activity continues.
5. Evaluate and treat hypoglycemia, electrolyte disturbance, infection, stroke, toxin, withdrawal, or eclampsia in parallel.
6. If seizure persists after benzodiazepine plus second-line therapy, intubate when required and start continuous EEG-guided anesthetic treatment.
7. After clinical convulsions stop, confirm recovery or exclude nonconvulsive status.
8. Establish maintenance therapy and disposition based on cause, neurologic findings, recurrence risk, and complications.

Clinical Synopsis & Reasoning

Recognize generalized tonic-clonic activity lasting 5 minutes or more, or repeated seizures without meaningful recovery. Simultaneously stabilize airway and oxygenation, protect from injury, check bedside glucose, obtain IV or intraosseous access when feasible, and document seizure onset time. Do not place objects in the mouth and do not restrain tonic-clonic movements. Hypoglycemia, hyponatremia, infection, stroke, medication nonadherence, alcohol withdrawal, toxic exposure, pregnancy-related eclampsia, and structural brain disease are important causes. If convulsions stop but consciousness does not improve, consider nonconvulsive status epilepticus and obtain urgent EEG. Fever, meningismus, immunocompromise, or persistent encephalopathy may require lumbar puncture after stabilization; focal deficits or first seizure often warrant neuroimaging. A common cause of treatment failure is underdosing the initial benzodiazepine because of fear of respiratory depression. Ongoing seizure itself threatens ventilation and can produce lactic acidosis, hyperthermia, rhabdomyolysis, aspiration, and neuronal injury. In pregnant or postpartum patients with suspected eclampsia, magnesium sulfate is the disease-specific first-line anticonvulsant and obstetric management is urgent.

Treatment Strategy & Disposition

Give an adequate benzodiazepine dose promptly. Intravenous lorazepam 0.1 mg/kg up to 4 mg per dose, repeat once if needed, is common when IV access is present. Intramuscular midazolam 10 mg is effective for adults over 40 kg when IV access is not immediately available. If seizure persists, load a second-line antiseizure medication without waiting for repeated small benzodiazepine doses. Evidence supports levetiracetam 60 mg/kg up to 4,500 mg, fosphenytoin 20 mg PE/kg up to 1,500 mg PE, or valproate 40 mg/kg up to 3,000 mg as reasonable options, selected around contraindications and comorbidities. Correct the precipitating metabolic disorder in parallel. Refractory status epilepticus after an adequate benzodiazepine and second-line load generally requires intubation, continuous EEG, and an anesthetic infusion such as propofol or midazolam under neurocritical-care guidance. Pyridoxine is indicated for isoniazid toxicity; magnesium for eclampsia; and antimicrobials are started promptly when CNS infection is suspected. Continue a maintenance antiseizure plan after seizure control according to cause and recurrence risk.

Epidemiology / Risk Factors

• Status epilepticus occurs in people with known epilepsy and as the first manifestation of acute neurologic or systemic disease.
• Medication nonadherence, stroke, infection, metabolic disturbance, alcohol withdrawal, and toxic exposure are frequent precipitants.
• Older adults have higher rates of acute symptomatic causes and higher mortality.
• Longer seizure duration before effective treatment is associated with pharmacoresistance and worse outcomes.
• Rapid prehospital benzodiazepine treatment is an important part of modern status systems of care.

Investigations

Drug Loading Doses (Adults)

Pharmacology

Prognosis / Complications

• Outcome depends more on the underlying cause, age, duration, and refractoriness than on the seizure alone.
• Short status caused by reversible medication nonadherence often has a better prognosis than status caused by anoxic injury, large stroke, or encephalitis.
• Prolonged convulsive activity can cause aspiration, hyperthermia, rhabdomyolysis, acidosis, arrhythmia, and neurologic injury.
• Refractory and super-refractory status have substantial mortality and frequently require prolonged intensive care.
• Patients with a first seizure or a new provoking lesion need cause-specific follow-up even after complete neurologic recovery.

Patient Education / Counseling

• For patients with epilepsy, review exact maintenance medication dosing and identify why doses were missed before discharge.
• Provide a rescue-seizure plan to the patient and caregivers when recurrent prolonged seizures are a risk.
• Discuss driving and occupational restrictions according to local law and specialist guidance.
• Advise emergency activation for a seizure lasting 5 minutes, repeated seizures without recovery, significant injury, pregnancy, or breathing difficulty.
• Explain that persistent confusion after visible shaking stops may still require urgent assessment because electrographic seizure can continue.

Notes

Status epilepticus care is a race against seizure duration, not a sequence of low-dose medication trials. The first benzodiazepine should be given at an effective dose, and a full second-line load should be ready if the seizure continues. At the same time, the team must find and treat the reason for the seizure, especially glucose disturbance, sodium abnormality, CNS infection, stroke, toxin, withdrawal, or eclampsia. When convulsions persist despite appropriate first- and second-line therapy, management becomes a neurocritical-care problem requiring airway control and continuous EEG rather than repeated bedside guessing about whether seizure activity has stopped.

References

1. American Epilepsy Society Guideline for Treatment of Convulsive Status Epilepticus — Link